These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 395072)

  • 1. Use of an artificial beta cell in surgery.
    Horwitz DL; Schwartz SS
    Horm Metab Res Suppl; 1979; (8):156-8. PubMed ID: 395072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.
    Altomare E; Moulin JP; Tavares S; Bourelly N; Lassmann V; Vague P
    Horm Metab Res Suppl; 1979; (8):110-5. PubMed ID: 395065
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutical application of artificial beta-cell in surgery and obstetrics.
    Brunetti P; Puxeddu A; Calabrese G; Massi-Benedetti M; Santeusanio F; Bolli G; Scionti L; Bueti A; Angeletti G
    Horm Metab Res Suppl; 1979; (8):162-5. PubMed ID: 395074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of daily insulin requirements in diabetics with an artificial endocrine pancreas.
    Lambert AE; Buysschaert M; Lambotte L
    Horm Metab Res Suppl; 1979; (8):120-7. PubMed ID: 395067
    [No Abstract]   [Full Text] [Related]  

  • 5. Control algorithms for artificial beta cell.
    Clemens AH
    Horm Metab Res Suppl; 1979; (8):35-8. PubMed ID: 395086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The artificial beta cell (Biostator) in the adjustment of instable diabetics--results after 20 months.
    Beyer J; Wolf E; Cordes U; Hassingen W
    Horm Metab Res Suppl; 1979; (8):127-31. PubMed ID: 395068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of an artificial endocrine pancreas in the management of the diabetic surgical patient.
    Kerner W; Beischer W; Herfarth C; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):159-61. PubMed ID: 395073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
    Christiansen JS; Svendsen PA; Deckert T
    Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a closed-loop artificial pancreas.
    Kraegen EW; Whiteside R; Bell D; Chia YO; Lazarus L
    Horm Metab Res Suppl; 1979; (8):38-42. PubMed ID: 395087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
    Kerner W; Beischer W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system).
    Pfeiffer EF; Thum C; Clemens AH
    Horm Metab Res; 1974 Sep; 6(5):339-42. PubMed ID: 4607598
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.
    Stavljenić A; Granić M; Topić B; Skrabalo Z
    Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of pre-programmed insulin infusion: continuous subcutaneous insulin therapy with a portable infusion system.
    Pickup JC; Viberti GC; Keen H; Parsons JA; Alberti KG
    Horm Metab Res Suppl; 1979; (8):202-4. PubMed ID: 395081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood glucose monitoring and computer regulation by means of an artificial endocrine pancreas.
    Kruse-Jarres JD; Braun G; Naegele R; Bresch M; Lehmann U
    Horm Metab Res Suppl; 1979; (8):42-5. PubMed ID: 395088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
    Schock A; Schultz M; Kerner W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal blood sugar control in labile diabetics using a portable open-loop insulin infusion system with a flexible program.
    Froesch ER; Blatter G; Morell B
    Horm Metab Res Suppl; 1979; (8):198-201. PubMed ID: 395079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of artificial beta cell in diagnosis and treatment of insulinoma.
    Raptis S; Zoupas C; Dimitriadis G; Moulopoulos S
    Horm Metab Res Suppl; 1979; (8):169-72. PubMed ID: 231567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closed-loop system in evaluation of insulin infusion rates for an open-loop system.
    Kølendorf K; Christiansen JS; Svendsen PA; Bojsen J
    Horm Metab Res Suppl; 1979; (8):205-6. PubMed ID: 395082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer-controlled bedside monitoring and infusion system.
    Sailer D; Berg G
    Horm Metab Res Suppl; 1979; (8):45-8. PubMed ID: 43830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation induced by a three-days application of the artificial beta-cell on glucagon, growth hormone and catecholamine secretion, glycosylated hemoglobin, and erythrocyte 2,3-diphosphoglycerate concentration.
    Brunetti P; Massi-Benedetti M; Puxeddu A; Santeusanio F; Calabrese G; Bolli G; Scionti L; Angeletti G
    Horm Metab Res Suppl; 1979; (8):81-6. PubMed ID: 395095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.